nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobunolol—Ataxia—Paclitaxel—lung cancer	0.00314	0.00316	CcSEcCtD
Levobunolol—Cardiac failure congestive—Docetaxel—lung cancer	0.00312	0.00314	CcSEcCtD
Levobunolol—Syncope—Erlotinib—lung cancer	0.0031	0.00312	CcSEcCtD
Levobunolol—Nausea—Crizotinib—lung cancer	0.00309	0.00311	CcSEcCtD
Levobunolol—Arrhythmia—Vinorelbine—lung cancer	0.00307	0.00309	CcSEcCtD
Levobunolol—Urticaria—Teniposide—lung cancer	0.00305	0.00308	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Gemcitabine—lung cancer	0.00304	0.00307	CcSEcCtD
Levobunolol—Loss of consciousness—Erlotinib—lung cancer	0.00304	0.00306	CcSEcCtD
Levobunolol—Alopecia—Vinorelbine—lung cancer	0.00303	0.00305	CcSEcCtD
Levobunolol—Stinging—Doxorubicin—lung cancer	0.003	0.00302	CcSEcCtD
Levobunolol—Visual disturbance—Docetaxel—lung cancer	0.00298	0.003	CcSEcCtD
Levobunolol—Chest pain—Topotecan—lung cancer	0.00297	0.00299	CcSEcCtD
Levobunolol—Chest pain—Erlotinib—lung cancer	0.00294	0.00296	CcSEcCtD
Levobunolol—Bronchospasm—Etoposide—lung cancer	0.00289	0.00291	CcSEcCtD
Levobunolol—Lethargy—Docetaxel—lung cancer	0.00289	0.00291	CcSEcCtD
Levobunolol—Bradycardia—Irinotecan—lung cancer	0.00288	0.0029	CcSEcCtD
Levobunolol—Respiratory failure—Methotrexate—lung cancer	0.00286	0.00288	CcSEcCtD
Levobunolol—Hypersensitivity—Teniposide—lung cancer	0.00283	0.00285	CcSEcCtD
Levobunolol—Nausea—Pemetrexed—lung cancer	0.00282	0.00284	CcSEcCtD
Levobunolol—Nausea—Gefitinib—lung cancer	0.0028	0.00282	CcSEcCtD
Levobunolol—Conjunctivitis—Cisplatin—lung cancer	0.00278	0.0028	CcSEcCtD
Levobunolol—Shock—Erlotinib—lung cancer	0.00277	0.00279	CcSEcCtD
Levobunolol—Asthenia—Teniposide—lung cancer	0.00276	0.00278	CcSEcCtD
Levobunolol—Visual impairment—Irinotecan—lung cancer	0.00273	0.00275	CcSEcCtD
Levobunolol—Pruritus—Teniposide—lung cancer	0.00272	0.00274	CcSEcCtD
Levobunolol—Ataxia—Docetaxel—lung cancer	0.00266	0.00268	CcSEcCtD
Levobunolol—Palpitations—Vinorelbine—lung cancer	0.00264	0.00266	CcSEcCtD
Levobunolol—Timolol—ABCB1—lung cancer	0.00263	0.388	CrCbGaD
Levobunolol—Paraesthesia—Vinblastine—lung cancer	0.00263	0.00265	CcSEcCtD
Levobunolol—Diarrhoea—Teniposide—lung cancer	0.00263	0.00265	CcSEcCtD
Levobunolol—Bradycardia—Cisplatin—lung cancer	0.00262	0.00263	CcSEcCtD
Levobunolol—Erythema multiforme—Gemcitabine—lung cancer	0.00261	0.00262	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Etoposide—lung cancer	0.0026	0.00262	CcSEcCtD
Levobunolol—Depression—Paclitaxel—lung cancer	0.00256	0.00258	CcSEcCtD
Levobunolol—Paraesthesia—Topotecan—lung cancer	0.00256	0.00258	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Paclitaxel—lung cancer	0.00255	0.00257	CcSEcCtD
Levobunolol—Chest pain—Vinorelbine—lung cancer	0.00254	0.00256	CcSEcCtD
Levobunolol—Dyspnoea—Topotecan—lung cancer	0.00254	0.00256	CcSEcCtD
Levobunolol—Arrhythmia—Irinotecan—lung cancer	0.00253	0.00255	CcSEcCtD
Levobunolol—Dyspnoea—Erlotinib—lung cancer	0.00251	0.00253	CcSEcCtD
Levobunolol—Pain—Vinblastine—lung cancer	0.00251	0.00253	CcSEcCtD
Levobunolol—Atrioventricular block—Doxorubicin—lung cancer	0.00251	0.00252	CcSEcCtD
Levobunolol—Alopecia—Irinotecan—lung cancer	0.0025	0.00252	CcSEcCtD
Levobunolol—Conjunctivitis—Paclitaxel—lung cancer	0.0025	0.00252	CcSEcCtD
Levobunolol—Visual impairment—Cisplatin—lung cancer	0.00248	0.00249	CcSEcCtD
Levobunolol—Arrhythmia—Gemcitabine—lung cancer	0.00246	0.00248	CcSEcCtD
Levobunolol—Pain—Topotecan—lung cancer	0.00244	0.00245	CcSEcCtD
Levobunolol—Alopecia—Gemcitabine—lung cancer	0.00244	0.00245	CcSEcCtD
Levobunolol—Feeling abnormal—Vinblastine—lung cancer	0.00242	0.00243	CcSEcCtD
Levobunolol—Pain—Erlotinib—lung cancer	0.00241	0.00243	CcSEcCtD
Levobunolol—Headache—Teniposide—lung cancer	0.00241	0.00243	CcSEcCtD
Levobunolol—Bronchospasm—Docetaxel—lung cancer	0.0024	0.00242	CcSEcCtD
Levobunolol—Bradycardia—Paclitaxel—lung cancer	0.00235	0.00237	CcSEcCtD
Levobunolol—Feeling abnormal—Topotecan—lung cancer	0.00235	0.00236	CcSEcCtD
Levobunolol—Diabetes mellitus—Methotrexate—lung cancer	0.00234	0.00236	CcSEcCtD
Levobunolol—Arrhythmia—Cisplatin—lung cancer	0.0023	0.00231	CcSEcCtD
Levobunolol—Nausea—Teniposide—lung cancer	0.00228	0.0023	CcSEcCtD
Levobunolol—Hypotension—Vinorelbine—lung cancer	0.00228	0.00229	CcSEcCtD
Levobunolol—Alopecia—Cisplatin—lung cancer	0.00227	0.00229	CcSEcCtD
Levobunolol—Urticaria—Topotecan—lung cancer	0.00226	0.00228	CcSEcCtD
Levobunolol—Erythema multiforme—Etoposide—lung cancer	0.00223	0.00224	CcSEcCtD
Levobunolol—Visual impairment—Paclitaxel—lung cancer	0.00222	0.00224	CcSEcCtD
Levobunolol—Syncope—Irinotecan—lung cancer	0.00221	0.00222	CcSEcCtD
Levobunolol—Paraesthesia—Vinorelbine—lung cancer	0.00219	0.0022	CcSEcCtD
Levobunolol—Erythema multiforme—Paclitaxel—lung cancer	0.00218	0.0022	CcSEcCtD
Levobunolol—Dyspnoea—Vinorelbine—lung cancer	0.00217	0.00219	CcSEcCtD
Levobunolol—Loss of consciousness—Irinotecan—lung cancer	0.00217	0.00218	CcSEcCtD
Levobunolol—Hypersensitivity—Vinblastine—lung cancer	0.00216	0.00218	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.00216	0.00218	CcSEcCtD
Levobunolol—Visual disturbance—Methotrexate—lung cancer	0.00215	0.00217	CcSEcCtD
Levobunolol—Conjunctivitis—Docetaxel—lung cancer	0.00212	0.00213	CcSEcCtD
Levobunolol—Asthenia—Vinblastine—lung cancer	0.0021	0.00212	CcSEcCtD
Levobunolol—Hypersensitivity—Topotecan—lung cancer	0.0021	0.00211	CcSEcCtD
Levobunolol—Nadolol—ABCB1—lung cancer	0.00209	0.308	CrCbGaD
Levobunolol—Pain—Vinorelbine—lung cancer	0.00208	0.0021	CcSEcCtD
Levobunolol—Alopecia—Etoposide—lung cancer	0.00208	0.00209	CcSEcCtD
Levobunolol—Lethargy—Methotrexate—lung cancer	0.00208	0.00209	CcSEcCtD
Levobunolol—Cerebrovascular accident—Methotrexate—lung cancer	0.00208	0.00209	CcSEcCtD
Levobunolol—Arrhythmia—Paclitaxel—lung cancer	0.00206	0.00208	CcSEcCtD
Levobunolol—Asthenia—Topotecan—lung cancer	0.00204	0.00206	CcSEcCtD
Levobunolol—Chest pain—Gemcitabine—lung cancer	0.00204	0.00206	CcSEcCtD
Levobunolol—Alopecia—Paclitaxel—lung cancer	0.00204	0.00205	CcSEcCtD
Levobunolol—Diabetes mellitus—Doxorubicin—lung cancer	0.00203	0.00204	CcSEcCtD
Levobunolol—Confusional state—Irinotecan—lung cancer	0.00203	0.00204	CcSEcCtD
Levobunolol—Asthenia—Erlotinib—lung cancer	0.00202	0.00204	CcSEcCtD
Levobunolol—Pruritus—Topotecan—lung cancer	0.00202	0.00203	CcSEcCtD
Levobunolol—Feeling abnormal—Vinorelbine—lung cancer	0.00201	0.00202	CcSEcCtD
Levobunolol—Diarrhoea—Vinblastine—lung cancer	0.00201	0.00202	CcSEcCtD
Levobunolol—Pruritus—Erlotinib—lung cancer	0.002	0.00201	CcSEcCtD
Levobunolol—Shock—Irinotecan—lung cancer	0.00198	0.00199	CcSEcCtD
Levobunolol—Diarrhoea—Topotecan—lung cancer	0.00195	0.00196	CcSEcCtD
Levobunolol—Cardiac failure congestive—Doxorubicin—lung cancer	0.00195	0.00196	CcSEcCtD
Levobunolol—Dizziness—Vinblastine—lung cancer	0.00194	0.00195	CcSEcCtD
Levobunolol—Urticaria—Vinorelbine—lung cancer	0.00194	0.00195	CcSEcCtD
Levobunolol—Diarrhoea—Erlotinib—lung cancer	0.00193	0.00194	CcSEcCtD
Levobunolol—Ataxia—Methotrexate—lung cancer	0.00192	0.00193	CcSEcCtD
Levobunolol—Visual impairment—Docetaxel—lung cancer	0.00189	0.0019	CcSEcCtD
Levobunolol—Dizziness—Topotecan—lung cancer	0.00188	0.0019	CcSEcCtD
Levobunolol—Hypotension—Irinotecan—lung cancer	0.00188	0.00189	CcSEcCtD
Levobunolol—Dizziness—Erlotinib—lung cancer	0.00186	0.00188	CcSEcCtD
Levobunolol—Erythema multiforme—Docetaxel—lung cancer	0.00185	0.00186	CcSEcCtD
Levobunolol—Headache—Vinblastine—lung cancer	0.00184	0.00185	CcSEcCtD
Levobunolol—Hypotension—Gemcitabine—lung cancer	0.00183	0.00184	CcSEcCtD
Levobunolol—Hypoglycaemia—Doxorubicin—lung cancer	0.00181	0.00182	CcSEcCtD
Levobunolol—Paraesthesia—Irinotecan—lung cancer	0.00181	0.00182	CcSEcCtD
Levobunolol—Syncope—Paclitaxel—lung cancer	0.0018	0.00181	CcSEcCtD
Levobunolol—Loss of consciousness—Etoposide—lung cancer	0.0018	0.00181	CcSEcCtD
Levobunolol—Cerebrovascular accident—Doxorubicin—lung cancer	0.0018	0.00181	CcSEcCtD
Levobunolol—Lethargy—Doxorubicin—lung cancer	0.0018	0.00181	CcSEcCtD
Levobunolol—Hypersensitivity—Vinorelbine—lung cancer	0.0018	0.00181	CcSEcCtD
Levobunolol—Dyspnoea—Irinotecan—lung cancer	0.00179	0.0018	CcSEcCtD
Levobunolol—Headache—Topotecan—lung cancer	0.00179	0.0018	CcSEcCtD
Levobunolol—Palpitations—Paclitaxel—lung cancer	0.00178	0.00179	CcSEcCtD
Levobunolol—Headache—Erlotinib—lung cancer	0.00177	0.00178	CcSEcCtD
Levobunolol—Loss of consciousness—Paclitaxel—lung cancer	0.00177	0.00178	CcSEcCtD
Levobunolol—Diplopia—Doxorubicin—lung cancer	0.00176	0.00178	CcSEcCtD
Levobunolol—Paraesthesia—Gemcitabine—lung cancer	0.00176	0.00177	CcSEcCtD
Levobunolol—Asthenia—Vinorelbine—lung cancer	0.00175	0.00176	CcSEcCtD
Levobunolol—Arrhythmia—Docetaxel—lung cancer	0.00175	0.00176	CcSEcCtD
Levobunolol—Dyspnoea—Gemcitabine—lung cancer	0.00175	0.00176	CcSEcCtD
Levobunolol—Chest pain—Etoposide—lung cancer	0.00174	0.00176	CcSEcCtD
Levobunolol—Nausea—Vinblastine—lung cancer	0.00174	0.00175	CcSEcCtD
Levobunolol—Alopecia—Docetaxel—lung cancer	0.00173	0.00174	CcSEcCtD
Levobunolol—Pruritus—Vinorelbine—lung cancer	0.00172	0.00174	CcSEcCtD
Levobunolol—Pain—Irinotecan—lung cancer	0.00172	0.00173	CcSEcCtD
Levobunolol—Chest pain—Paclitaxel—lung cancer	0.00171	0.00172	CcSEcCtD
Levobunolol—Hypotension—Cisplatin—lung cancer	0.00171	0.00172	CcSEcCtD
Levobunolol—Nausea—Topotecan—lung cancer	0.00169	0.0017	CcSEcCtD
Levobunolol—Confusional state—Etoposide—lung cancer	0.00169	0.0017	CcSEcCtD
Levobunolol—Cardiac arrest—Doxorubicin—lung cancer	0.00168	0.00169	CcSEcCtD
Levobunolol—Pain—Gemcitabine—lung cancer	0.00167	0.00169	CcSEcCtD
Levobunolol—Nausea—Erlotinib—lung cancer	0.00167	0.00169	CcSEcCtD
Levobunolol—Diarrhoea—Vinorelbine—lung cancer	0.00167	0.00168	CcSEcCtD
Levobunolol—Ataxia—Doxorubicin—lung cancer	0.00166	0.00167	CcSEcCtD
Levobunolol—Feeling abnormal—Irinotecan—lung cancer	0.00166	0.00167	CcSEcCtD
Levobunolol—Confusional state—Paclitaxel—lung cancer	0.00165	0.00166	CcSEcCtD
Levobunolol—Paraesthesia—Cisplatin—lung cancer	0.00164	0.00165	CcSEcCtD
Levobunolol—Dyspnoea—Cisplatin—lung cancer	0.00163	0.00164	CcSEcCtD
Levobunolol—Erectile dysfunction—Methotrexate—lung cancer	0.00162	0.00163	CcSEcCtD
Levobunolol—Feeling abnormal—Gemcitabine—lung cancer	0.00161	0.00163	CcSEcCtD
Levobunolol—Shock—Paclitaxel—lung cancer	0.00161	0.00162	CcSEcCtD
Levobunolol—Dizziness—Vinorelbine—lung cancer	0.00161	0.00162	CcSEcCtD
Levobunolol—Depression—Methotrexate—lung cancer	0.00157	0.00158	CcSEcCtD
Levobunolol—Hypotension—Etoposide—lung cancer	0.00156	0.00157	CcSEcCtD
Levobunolol—Pain—Cisplatin—lung cancer	0.00156	0.00157	CcSEcCtD
Levobunolol—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.00156	0.00157	CcSEcCtD
Levobunolol—Hypotension—Paclitaxel—lung cancer	0.00153	0.00154	CcSEcCtD
Levobunolol—Headache—Vinorelbine—lung cancer	0.00153	0.00154	CcSEcCtD
Levobunolol—Syncope—Docetaxel—lung cancer	0.00153	0.00154	CcSEcCtD
Levobunolol—Conjunctivitis—Methotrexate—lung cancer	0.00153	0.00154	CcSEcCtD
Levobunolol—Palpitations—Docetaxel—lung cancer	0.00151	0.00152	CcSEcCtD
Levobunolol—Feeling abnormal—Cisplatin—lung cancer	0.0015	0.00151	CcSEcCtD
Levobunolol—Paraesthesia—Etoposide—lung cancer	0.0015	0.00151	CcSEcCtD
Levobunolol—Loss of consciousness—Docetaxel—lung cancer	0.0015	0.00151	CcSEcCtD
Levobunolol—Dyspnoea—Etoposide—lung cancer	0.00149	0.0015	CcSEcCtD
Levobunolol—Hypersensitivity—Irinotecan—lung cancer	0.00148	0.00149	CcSEcCtD
Levobunolol—Paraesthesia—Paclitaxel—lung cancer	0.00147	0.00148	CcSEcCtD
Levobunolol—Dyspnoea—Paclitaxel—lung cancer	0.00146	0.00147	CcSEcCtD
Levobunolol—Chest pain—Docetaxel—lung cancer	0.00145	0.00146	CcSEcCtD
Levobunolol—Nausea—Vinorelbine—lung cancer	0.00145	0.00146	CcSEcCtD
Levobunolol—Asthenia—Irinotecan—lung cancer	0.00144	0.00145	CcSEcCtD
Levobunolol—Pain—Etoposide—lung cancer	0.00143	0.00144	CcSEcCtD
Levobunolol—Asthenia—Gemcitabine—lung cancer	0.00141	0.00141	CcSEcCtD
Levobunolol—Pain—Paclitaxel—lung cancer	0.0014	0.00141	CcSEcCtD
Levobunolol—Confusional state—Docetaxel—lung cancer	0.0014	0.00141	CcSEcCtD
Levobunolol—Pruritus—Gemcitabine—lung cancer	0.00139	0.0014	CcSEcCtD
Levobunolol—Feeling abnormal—Etoposide—lung cancer	0.00138	0.00139	CcSEcCtD
Levobunolol—Diarrhoea—Irinotecan—lung cancer	0.00138	0.00139	CcSEcCtD
Levobunolol—Shock—Docetaxel—lung cancer	0.00137	0.00138	CcSEcCtD
Levobunolol—Visual impairment—Methotrexate—lung cancer	0.00136	0.00137	CcSEcCtD
Levobunolol—Feeling abnormal—Paclitaxel—lung cancer	0.00135	0.00136	CcSEcCtD
Levobunolol—Propranolol—CYP1A1—lung cancer	0.00135	0.199	CrCbGaD
Levobunolol—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.00135	0.00136	CcSEcCtD
Levobunolol—Hypersensitivity—Cisplatin—lung cancer	0.00135	0.00135	CcSEcCtD
Levobunolol—Diarrhoea—Gemcitabine—lung cancer	0.00134	0.00135	CcSEcCtD
Levobunolol—Erythema multiforme—Methotrexate—lung cancer	0.00133	0.00134	CcSEcCtD
Levobunolol—Dizziness—Irinotecan—lung cancer	0.00133	0.00134	CcSEcCtD
Levobunolol—Urticaria—Etoposide—lung cancer	0.00133	0.00134	CcSEcCtD
Levobunolol—Conjunctivitis—Doxorubicin—lung cancer	0.00132	0.00133	CcSEcCtD
Levobunolol—Asthenia—Cisplatin—lung cancer	0.00131	0.00132	CcSEcCtD
Levobunolol—Urticaria—Paclitaxel—lung cancer	0.0013	0.00131	CcSEcCtD
Levobunolol—Hypotension—Docetaxel—lung cancer	0.0013	0.00131	CcSEcCtD
Levobunolol—Headache—Irinotecan—lung cancer	0.00126	0.00127	CcSEcCtD
Levobunolol—Diarrhoea—Cisplatin—lung cancer	0.00125	0.00126	CcSEcCtD
Levobunolol—Paraesthesia—Docetaxel—lung cancer	0.00125	0.00126	CcSEcCtD
Levobunolol—Alopecia—Methotrexate—lung cancer	0.00125	0.00125	CcSEcCtD
Levobunolol—Bradycardia—Doxorubicin—lung cancer	0.00124	0.00125	CcSEcCtD
Levobunolol—Dyspnoea—Docetaxel—lung cancer	0.00124	0.00125	CcSEcCtD
Levobunolol—Hypersensitivity—Etoposide—lung cancer	0.00123	0.00124	CcSEcCtD
Levobunolol—Headache—Gemcitabine—lung cancer	0.00123	0.00124	CcSEcCtD
Levobunolol—Hypersensitivity—Paclitaxel—lung cancer	0.00121	0.00122	CcSEcCtD
Levobunolol—Asthenia—Etoposide—lung cancer	0.0012	0.00121	CcSEcCtD
Levobunolol—Nausea—Irinotecan—lung cancer	0.00119	0.0012	CcSEcCtD
Levobunolol—Pain—Docetaxel—lung cancer	0.00119	0.0012	CcSEcCtD
Levobunolol—Pruritus—Etoposide—lung cancer	0.00118	0.00119	CcSEcCtD
Levobunolol—Visual impairment—Doxorubicin—lung cancer	0.00118	0.00118	CcSEcCtD
Levobunolol—Asthenia—Paclitaxel—lung cancer	0.00118	0.00118	CcSEcCtD
Levobunolol—Nausea—Gemcitabine—lung cancer	0.00116	0.00117	CcSEcCtD
Levobunolol—Pruritus—Paclitaxel—lung cancer	0.00116	0.00117	CcSEcCtD
Levobunolol—Erythema multiforme—Doxorubicin—lung cancer	0.00115	0.00116	CcSEcCtD
Levobunolol—Feeling abnormal—Docetaxel—lung cancer	0.00115	0.00115	CcSEcCtD
Levobunolol—Diarrhoea—Etoposide—lung cancer	0.00114	0.00115	CcSEcCtD
Levobunolol—Diarrhoea—Paclitaxel—lung cancer	0.00112	0.00113	CcSEcCtD
Levobunolol—Dizziness—Etoposide—lung cancer	0.00111	0.00111	CcSEcCtD
Levobunolol—Arrhythmia—Doxorubicin—lung cancer	0.00109	0.0011	CcSEcCtD
Levobunolol—Dizziness—Paclitaxel—lung cancer	0.00108	0.00109	CcSEcCtD
Levobunolol—Nausea—Cisplatin—lung cancer	0.00108	0.00109	CcSEcCtD
Levobunolol—Alopecia—Doxorubicin—lung cancer	0.00108	0.00109	CcSEcCtD
Levobunolol—Headache—Etoposide—lung cancer	0.00105	0.00105	CcSEcCtD
Levobunolol—Chest pain—Methotrexate—lung cancer	0.00105	0.00105	CcSEcCtD
Levobunolol—Headache—Paclitaxel—lung cancer	0.00103	0.00103	CcSEcCtD
Levobunolol—Hypersensitivity—Docetaxel—lung cancer	0.00102	0.00103	CcSEcCtD
Levobunolol—Confusional state—Methotrexate—lung cancer	0.00101	0.00102	CcSEcCtD
Levobunolol—Asthenia—Docetaxel—lung cancer	0.000997	0.001	CcSEcCtD
Levobunolol—Nausea—Etoposide—lung cancer	0.000993	0.001	CcSEcCtD
Levobunolol—Pruritus—Docetaxel—lung cancer	0.000983	0.00099	CcSEcCtD
Levobunolol—Nausea—Paclitaxel—lung cancer	0.000974	0.000981	CcSEcCtD
Levobunolol—Syncope—Doxorubicin—lung cancer	0.000953	0.00096	CcSEcCtD
Levobunolol—Diarrhoea—Docetaxel—lung cancer	0.000951	0.000958	CcSEcCtD
Levobunolol—Palpitations—Doxorubicin—lung cancer	0.000939	0.000946	CcSEcCtD
Levobunolol—Hypotension—Methotrexate—lung cancer	0.000936	0.000943	CcSEcCtD
Levobunolol—Loss of consciousness—Doxorubicin—lung cancer	0.000934	0.000941	CcSEcCtD
Levobunolol—Dizziness—Docetaxel—lung cancer	0.000919	0.000925	CcSEcCtD
Levobunolol—Chest pain—Doxorubicin—lung cancer	0.000905	0.000911	CcSEcCtD
Levobunolol—Paraesthesia—Methotrexate—lung cancer	0.0009	0.000906	CcSEcCtD
Levobunolol—Dyspnoea—Methotrexate—lung cancer	0.000893	0.000899	CcSEcCtD
Levobunolol—Confusional state—Doxorubicin—lung cancer	0.000875	0.000881	CcSEcCtD
Levobunolol—Headache—Docetaxel—lung cancer	0.000871	0.000877	CcSEcCtD
Levobunolol—Pain—Methotrexate—lung cancer	0.000857	0.000863	CcSEcCtD
Levobunolol—Shock—Doxorubicin—lung cancer	0.000853	0.000859	CcSEcCtD
Levobunolol—Nausea—Docetaxel—lung cancer	0.000826	0.000831	CcSEcCtD
Levobunolol—Feeling abnormal—Methotrexate—lung cancer	0.000826	0.000831	CcSEcCtD
Levobunolol—Hypotension—Doxorubicin—lung cancer	0.000811	0.000816	CcSEcCtD
Levobunolol—Urticaria—Methotrexate—lung cancer	0.000796	0.000801	CcSEcCtD
Levobunolol—Paraesthesia—Doxorubicin—lung cancer	0.000779	0.000784	CcSEcCtD
Levobunolol—Dyspnoea—Doxorubicin—lung cancer	0.000773	0.000779	CcSEcCtD
Levobunolol—Pain—Doxorubicin—lung cancer	0.000742	0.000747	CcSEcCtD
Levobunolol—Hypersensitivity—Methotrexate—lung cancer	0.000738	0.000743	CcSEcCtD
Levobunolol—Asthenia—Methotrexate—lung cancer	0.000719	0.000724	CcSEcCtD
Levobunolol—Propranolol—ABCB1—lung cancer	0.000718	0.106	CrCbGaD
Levobunolol—Feeling abnormal—Doxorubicin—lung cancer	0.000715	0.00072	CcSEcCtD
Levobunolol—Pruritus—Methotrexate—lung cancer	0.000709	0.000714	CcSEcCtD
Levobunolol—Urticaria—Doxorubicin—lung cancer	0.000689	0.000694	CcSEcCtD
Levobunolol—Diarrhoea—Methotrexate—lung cancer	0.000685	0.00069	CcSEcCtD
Levobunolol—Dizziness—Methotrexate—lung cancer	0.000662	0.000667	CcSEcCtD
Levobunolol—Hypersensitivity—Doxorubicin—lung cancer	0.000639	0.000643	CcSEcCtD
Levobunolol—Headache—Methotrexate—lung cancer	0.000628	0.000632	CcSEcCtD
Levobunolol—Asthenia—Doxorubicin—lung cancer	0.000622	0.000627	CcSEcCtD
Levobunolol—Pruritus—Doxorubicin—lung cancer	0.000614	0.000618	CcSEcCtD
Levobunolol—Nausea—Methotrexate—lung cancer	0.000595	0.000599	CcSEcCtD
Levobunolol—Diarrhoea—Doxorubicin—lung cancer	0.000594	0.000598	CcSEcCtD
Levobunolol—Dizziness—Doxorubicin—lung cancer	0.000574	0.000578	CcSEcCtD
Levobunolol—Headache—Doxorubicin—lung cancer	0.000543	0.000547	CcSEcCtD
Levobunolol—Nausea—Doxorubicin—lung cancer	0.000515	0.000519	CcSEcCtD
